Paolo Lanzetta

62PUBLICATIONS
105CO-AUTHORS
Optical technologyAutoimmunityEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Non-metal chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Jul 06, 2026
Switching to aflibercept 8 mg in neovascular age-related macular degeneration: real-world outcomes according to switch indication.

|Jun 25, 2026
Iridology: Biological plausibility, clinical evidence, and implications for ophthalmic practice : A position paper of the Associazione Pazienti Malattie Oculari (APMO).

|Jun 18, 2026
Enhanced S-cone syndrome in a family: first long-term (12-year) follow-up and literature review.

|Jun 13, 2026
Intraocular Pressure Outcomes with Intravitreal Aflibercept 8 mg: A 96-Week Pooled Analysis from PULSAR and PHOTON.

|Mar 21, 2026
"Flapless" trocar-assisted intrascleral fixation technique for Carlevale IOL implantation without conjunctival opening: A novel approach.

Petros Petrou, Spyridon Doumazos, Stylianos Kandarakis

|Feb 26, 2026
Reducing the Carbon Footprint of Neovascular Age-Related Macular Degeneration Therapy: Environmental Impact of Transitioning to Aflibercept 8 mg.

Daniele Veritti, Micaela Misciagna, Cristian Teatino

Pageof 11

Frequent Collaborators

17 joint publications

Daniele Veritti

14 joint publications

Valentina Sarao

8 joint publications

Francesco Bandello

6 joint publications

Carla Danese